[A comparative study of the membrane-protector efficacy of anaprilin and korinfar in hypertension patients].
Beta-blocker anapriline and calcium antagonist corinfar are highly effective hypotensive agents. Drop in diastolic arterial pressure with anapriline therapy amounted to 15.9 and 15.6%, with corinfar therapy-to 15.0 and 15.6% in hypertensive disease stage I and II respectively. Hypotensive action of corinfar might result from correction of impaired cation-transport function of cellular membranes, electrolyte homeostasis of cells, phospholipid composition of membranes. No dynamics has been revealed of the membrane tests under study during administration of anapriline therapy treatments.